{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T10:14:37Z","timestamp":1792664077053,"version":"4.5.0"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T00:00:00Z","timestamp":1567036800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T00:00:00Z","timestamp":1567036800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA011261"],"award-info":[{"award-number":["DA011261"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA046794"],"award-info":[{"award-number":["DA046794"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS088554"],"award-info":[{"award-number":["NS088554"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s12035-019-01739-x","type":"journal-article","created":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T23:28:59Z","timestamp":1567121339000},"page":"736-751","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Selective Regulation of 5-HT1B Serotonin Receptor Expression in the Striatum by Dopamine Depletion and Repeated L-DOPA Treatment: Relationship to L-DOPA-Induced Dyskinesias"],"prefix":"10.1007","volume":"57","author":[{"given":"Fernando E.","family":"Padovan-Neto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santanna","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nivea M.","family":"F. Voelkner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feras","family":"Altwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel A.","family":"Beverley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony R.","family":"West","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9139-1312","authenticated-orcid":false,"given":"Heinz","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,29]]},"reference":[{"key":"1739_CR1","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0028-3908(99)00010-6","volume":"38","author":"NM Barnes","year":"1999","unstructured":"Barnes NM, Sharp T (1999) A review of central 5-HT receptors and their function. Neuropharmacology 38:1083\u20131152","journal-title":"Neuropharmacology"},{"key":"1739_CR2","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.pneurobio.2016.03.004","volume":"151","author":"P De Deurwaerd\u00e8re","year":"2017","unstructured":"De Deurwaerd\u00e8re P, Di Giovanni G (2017) Serotonergic modulation of the activity of mesencephalic dopaminergic systems: therapeutic implications. Prog Neurobiol 151:175\u2013236","journal-title":"Prog Neurobiol"},{"key":"1739_CR3","first-page":"496","volume":"267","author":"RV Bhat","year":"1993","unstructured":"Bhat RV, Baraban JM (1993) Activation of transcription factor genes in striatum by cocaine: role of both serotonin and dopamine systems. J Pharmacol Exp Ther 267:496\u2013505","journal-title":"J Pharmacol Exp Ther"},{"key":"1739_CR4","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1124\/mol.51.5.755","volume":"51","author":"JJ Lucas","year":"1997","unstructured":"Lucas JJ, Segu L, Hen R (1997) 5-Hydroxytryptamine1B receptors modulate the effect of cocaine on c-Fos expression: converging evidence using 5-hydroxytryptamine1B knockout mice and the 5-hydroxytryptamine1B\/1D antagonist GR127935. Mol Pharmacol 51:755\u2013763","journal-title":"Mol Pharmacol"},{"key":"1739_CR5","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1037\/0735-7044.119.5.1173","volume":"119","author":"RP Szucs","year":"2005","unstructured":"Szucs RP, Frankel PS, McMahon LR, Cunningham KA (2005) Relationship of cocaine-induced c-Fos expression to behaviors and the role of serotonin 5-HT2A receptors in cocaine-induced c-Fos expression. Behav Neurosci 119:1173\u20131183","journal-title":"Behav Neurosci"},{"key":"1739_CR6","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.neuroscience.2004.10.030","volume":"131","author":"KA Horner","year":"2005","unstructured":"Horner KA, Adams DH, Hanson GR, Keefe KA (2005) Blockade of stimulant-induced preprodynorphin mRNA expression in the striatal matrix by serotonin depletion. Neuroscience 131:67\u201377","journal-title":"Neuroscience"},{"key":"1739_CR7","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s002210050545","volume":"123","author":"H Steiner","year":"1998","unstructured":"Steiner H, Gerfen CR (1998) Role of dynorphin and enkephalin in the regulation of striatal output pathways and behavior. Exp Brain Res 123:60\u201376","journal-title":"Exp Brain Res"},{"key":"1739_CR8","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1073\/pnas.88.4.1291","volume":"88","author":"ST Young","year":"1991","unstructured":"Young ST, Porrino LJ, Iadarola MJ (1991) Cocaine induces striatal c-Fos-immunoreactive proteins via dopaminergic D1 receptors. Proc Natl Acad Sci U S A 88:1291\u20131295","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1739_CR9","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1111\/j.1471-4159.1992.tb11358.x","volume":"58","author":"AJ Cole","year":"1992","unstructured":"Cole AJ, Bhat RV, Patt C, Worley PF, Baraban JM (1992) D1 dopamine receptor activation of multiple transcription factor genes in rat striatum. J Neurochem 58:1420\u20131426","journal-title":"J Neurochem"},{"key":"1739_CR10","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/cne.903530204","volume":"353","author":"H Steiner","year":"1995","unstructured":"Steiner H, Gerfen CR (1995) Dynorphin opioid inhibition of cocaine-induced, D1 dopamine receptor-mediated immediate-early gene expression in the striatum. J Comp Neurol 353:200\u2013212","journal-title":"J Comp Neurol"},{"key":"1739_CR11","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0091-3057(00)00389-0","volume":"67","author":"N Castanon","year":"2000","unstructured":"Castanon N, Scearce-Levie K, Lucas JJ, Rocha B, Hen R (2000) Modulation of the effects of cocaine by 5-HT1B receptors: a comparison of knockouts and antagonists. Pharmacol Biochem Behav 67:559\u2013566","journal-title":"Pharmacol Biochem Behav"},{"key":"1739_CR12","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.neuropharm.2014.08.024","volume":"89","author":"V Van Waes","year":"2015","unstructured":"Van Waes V, Ehrlich S, Beverley JA, Steiner H (2015) Fluoxetine potentiation of methylphenidate-induced gene regulation in striatal output pathways: potential role for 5-HT1B receptor. Neuropharmacology 89:77\u201386","journal-title":"Neuropharmacology"},{"key":"1739_CR13","first-page":"207","volume-title":"Fluoxetine: pharmacology, mechanisms of action and potential side effects","author":"V Van Waes","year":"2015","unstructured":"Van Waes V, Steiner H (2015) Fluoxetine and other SSRI antidepressants potentiate addiction-related gene regulation by psychostimulant medications. In: Pinna G (ed) Fluoxetine: pharmacology, mechanisms of action and potential side effects. Nova Science Publishers, Hauppauge, pp. 207\u2013225"},{"key":"1739_CR14","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1177\/0269881117715598","volume":"31","author":"D Alter","year":"2017","unstructured":"Alter D, Beverley JA, Patel R, Bola\u00f1os-Guzm\u00e1n CA, Steiner H (2017) The 5-HT1B serotonin receptor regulates methylphenidate-induced gene expression in the striatum: differential effects on immediate-early genes. J Psychopharmacol 31:1078\u20131087","journal-title":"J Psychopharmacol"},{"key":"1739_CR15","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.bbr.2011.06.016","volume":"224","author":"AR Furay","year":"2011","unstructured":"Furay AR, McDevitt RA, Miczek KA, Neumaier JF (2011) 5-HT1B mRNA expression after chronic social stress. Behav Brain Res 224:350\u2013357","journal-title":"Behav Brain Res"},{"key":"1739_CR16","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1001\/archgenpsychiatry.2011.91","volume":"68","author":"JW Murrough","year":"2011","unstructured":"Murrough JW, Czermak C, Henry S, Nabulsi N, Gallezot JD, Gueorguieva R, Planeta-Wilson B, Krystal JH et al (2011) The effect of early trauma exposure on serotonin type 1B receptor expression revealed by reduced selective radioligand binding. Arch Gen Psychiatry 68:892\u2013900","journal-title":"Arch Gen Psychiatry"},{"key":"1739_CR17","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.biopsych.2012.03.024","volume":"72","author":"NS Pentkowski","year":"2012","unstructured":"Pentkowski NS, Cheung TH, Toy WA, Adams MD, Neumaier JF, Neisewander JL (2012) Protracted withdrawal from cocaine self-administration flips the switch on 5-HT(1B) receptor modulation of cocaine abuse-related behaviors. Biol Psychiatry 72:396\u2013404","journal-title":"Biol Psychiatry"},{"key":"1739_CR18","doi-asserted-by":"crossref","first-page":"4578","DOI":"10.1073\/pnas.1401819111","volume":"111","author":"M Heiman","year":"2014","unstructured":"Heiman M, Heilbut A, Francardo V, Kulicke R, Fenster RJ, Kolaczyk ED, Mesirov JP, Surmeier DJ et al (2014) Molecular adaptations of striatal spiny projection neurons during levodopa-induced dyskinesia. Proc Natl Acad Sci U S A 111:4578\u20134583","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1739_CR19","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.neuropharm.2006.08.013","volume":"52","author":"BJ Hoplight","year":"2007","unstructured":"Hoplight BJ, Vincow ES, Neumaier JF (2007) Cocaine increases 5-HT1B mRNA in rat nucleus accumbens shell neurons. Neuropharmacology 52:444\u2013449","journal-title":"Neuropharmacology"},{"key":"1739_CR20","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1471-4159.2009.06313.x","volume":"111","author":"JF Neumaier","year":"2009","unstructured":"Neumaier JF, McDevitt RA, Polis IY, Parsons LH (2009) Acquisition of and withdrawal from cocaine self-administration regulates 5-HT mRNA expression in rat striatum. J Neurochem 111:217\u2013227","journal-title":"J Neurochem"},{"key":"1739_CR21","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3389\/fneur.2014.00078","volume":"5","author":"M Carta","year":"2014","unstructured":"Carta M, Tronci E (2014) Serotonin system implication in l-DOPA-induced dyskinesia: from animal models to clinical investigations. Front Neurol 5:78","journal-title":"Front Neurol"},{"key":"1739_CR22","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1007\/s00702-017-1837-1","volume":"125","author":"K Lanza","year":"2018","unstructured":"Lanza K, Bishop C (2018) Serotonergic targets for the treatment of L-DOPA-induced dyskinesia. J Neural Transm 125:1203\u20131216","journal-title":"J Neural Transm"},{"key":"1739_CR23","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1073\/pnas.0711839105","volume":"105","author":"X Zhang","year":"2008","unstructured":"Zhang X, Andren PE, Greengard P, Svenningsson P (2008) Evidence for a role of the 5-HT1B receptor and its adaptor protein, p11, in L-DOPA treatment of an animal model of Parkinsonism. Proc Natl Acad Sci U S A 105:2163\u20132168","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1739_CR24","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.bcp.2013.08.005","volume":"86","author":"G Riahi","year":"2013","unstructured":"Riahi G, Morissette M, Samadi P, Parent M, Di Paolo T (2013) Basal ganglia serotonin 1B receptors in parkinsonian monkeys with L-DOPA-induced dyskinesia. Biochem Pharmacol 86:970\u2013978","journal-title":"Biochem Pharmacol"},{"key":"1739_CR25","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.neuropharm.2015.08.002","volume":"99","author":"N Morin","year":"2015","unstructured":"Morin N, Morissette M, Gr\u00e9goire L, Rajput A, Rajput AH, Di Paolo T (2015) Contribution of brain serotonin subtype 1B receptors in levodopa-induced motor complications. Neuropharmacology 99:356\u2013368","journal-title":"Neuropharmacology"},{"key":"1739_CR26","volume":"6","author":"KY Tseng","year":"2011","unstructured":"Tseng KY, Caballero A, Dec A, Cass DK, Simak N, Sunu E, Park MJ, Blume SR et al (2011) Inhibition of striatal soluble guanylyl cyclase-cGMP signaling reverses basal ganglia dysfunction and akinesia in experimental parkinsonism. PLoS One 6:e27187","journal-title":"PLoS One"},{"key":"1739_CR27","volume-title":"The rat brain in stereotaxic coordinates","author":"G Paxinos","year":"1998","unstructured":"Paxinos G, Watson C (1998) The rat brain in stereotaxic coordinates. Academic Press, New York"},{"key":"1739_CR28","first-page":"625","volume":"27","author":"VR Jayasinghe","year":"2017","unstructured":"Jayasinghe VR, Flores-Barrera E, West AR, Tseng KY (2017) Frequency-dependent corticostriatal disinhibition resulting from chronic dopamine depletion: role of local striatal cGMP and GABA-AR signaling. Cereb Cortex 27:625\u2013634","journal-title":"Cereb Cortex"},{"key":"1739_CR29","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.neuropharm.2014.08.019","volume":"89","author":"FE Padovan-Neto","year":"2015","unstructured":"Padovan-Neto FE, Cavalcanti-Kiwiatkoviski R, Carolino RO, Anselmo-Franci J, Del Bel E (2015) Effects of prolonged neuronal nitric oxide synthase inhibition on the development and expression of L-DOPA-induced dyskinesia in 6-OHDA-lesioned rats. Neuropharmacology 89:87\u201399","journal-title":"Neuropharmacology"},{"key":"1739_CR30","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1006\/nbdi.2002.0499","volume":"10","author":"C Winkler","year":"2002","unstructured":"Winkler C, Kirik D, Bj\u00f6rklund A, Cenci MA (2002) L-DOPA-induced dyskinesia in the intrastriatal 6-hydroxydopamine model of Parkinson\u2019s disease: relation to motor and cellular parameters of nigrostriatal function. Neurobiol Dis 10:165\u2013186","journal-title":"Neurobiol Dis"},{"key":"1739_CR31","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1046\/j.1460-9568.1998.00285.x","volume":"10","author":"MA Cenci","year":"1998","unstructured":"Cenci MA, Lee CS, Bj\u00f6rklund A (1998) L-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA. Eur J Neurosci 10:2694\u20132708","journal-title":"Eur J Neurosci"},{"key":"1739_CR32","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.neuroscience.2009.01.034","volume":"159","author":"FE Padovan-Neto","year":"2009","unstructured":"Padovan-Neto FE, Echeverry MB, Tumas V, Del-Bel EA (2009) Nitric oxide synthase inhibition attenuates L-DOPA-induced dyskinesias in a rodent model of Parkinson\u2019s disease. Neuroscience 159:927\u2013935","journal-title":"Neuroscience"},{"key":"1739_CR33","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1046\/j.0953-816x.2001.01843.x","volume":"15","author":"M Lundblad","year":"2002","unstructured":"Lundblad M, Andersson M, Winkler C, Kirik D, Wierup N, Cenci MA (2002) Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson\u2019s disease. Eur J Neurosci 15:120\u2013132","journal-title":"Eur J Neurosci"},{"key":"1739_CR34","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1046\/j.0953-816x.2001.01756.x","volume":"14","author":"H Steiner","year":"2001","unstructured":"Steiner H, Kitai ST (2001) Unilateral striatal dopamine depletion: time-dependent effects on cortical function and behavioural correlates. Eur J Neurosci 14:1390\u20131404","journal-title":"Eur J Neurosci"},{"key":"1739_CR35","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1046\/j.1460-9568.2003.02525.x","volume":"17","author":"I Willuhn","year":"2003","unstructured":"Willuhn I, Sun W, Steiner H (2003) Topography of cocaine-induced gene regulation in the rat striatum: relationship to cortical inputs and role of behavioural context. Eur J Neurosci 17:1053\u20131066","journal-title":"Eur J Neurosci"},{"key":"1739_CR36","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1006\/exnr.1999.7163","volume":"159","author":"H Steiner","year":"1999","unstructured":"Steiner H, Blum M, Kitai ST, Fedi P (1999) Differential expression of ErbB3 and ErbB4 neuregulin receptors in dopamine neurons and forebrain areas of the adult rat. Exp Neurol 159:494\u2013503","journal-title":"Exp Neurol"},{"key":"1739_CR37","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.neuroscience.2004.12.019","volume":"132","author":"M Yano","year":"2005","unstructured":"Yano M, Steiner H (2005) Methylphenidate (Ritalin) induces Homer 1a and zif 268 expression in specific corticostriatal circuits. Neuroscience 132:855\u2013865","journal-title":"Neuroscience"},{"key":"1739_CR38","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0306-4522(98)00217-6","volume":"88","author":"JW Chang","year":"1999","unstructured":"Chang JW, Wachtel SR, Young D, Kang UJ (1999) Biochemical and anatomical characterization of forepaw adjusting steps in rat models of Parkinson\u2019s disease: studies on medial forebrain bundle and striatal lesions. Neuroscience 88:617\u2013628","journal-title":"Neuroscience"},{"key":"1739_CR39","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0169-328X(95)00317-L","volume":"37","author":"LK Nisenbaum","year":"1996","unstructured":"Nisenbaum LK, Crowley WR, Kitai ST (1996) Partial striatal dopamine depletion differentially affects striatal substance P and enkephalin messenger RNA expression. Mol Brain Res 37:209\u2013216","journal-title":"Mol Brain Res"},{"key":"1739_CR40","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/0166-2236(90)90112-N","volume":"13","author":"MJ Zigmond","year":"1990","unstructured":"Zigmond MJ, Abercrombie ED, Berger TW, Grace AA, Stricker EM (1990) Compensations after lesions of central dopaminergic neurons: some clinical and basic implications. Trends Neurosci 13:290\u2013296","journal-title":"Trends Neurosci"},{"key":"1739_CR41","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1006\/exnr.1998.6996","volume":"155","author":"B Henry","year":"1999","unstructured":"Henry B, Crossman AR, Brotchie JM (1999) Effect of repeated L-DOPA, bromocriptine, or lisuride administration on preproenkephalin-A and preproenkephalin-B mRNA levels in the striatum of the 6-hydroxydopamine-lesioned rat. Exp Neurol 155:204\u2013220","journal-title":"Exp Neurol"},{"key":"1739_CR42","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1006\/exnr.2001.7647","volume":"169","author":"W Pirker","year":"2001","unstructured":"Pirker W, Tedroff J, Pont\u00e9n H, Gunne L, Andr\u00e9n PE, Hurd YL (2001) Coadministration of (-)-OSU6162 with l-DOPA normalizes preproenkephalin mRNA expression in the sensorimotor striatum of primates with unilateral 6-OHDA lesions. Exp Neurol 169:122\u2013134","journal-title":"Exp Neurol"},{"key":"1739_CR43","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1093\/jnen\/61.2.186","volume":"61","author":"F Calon","year":"2002","unstructured":"Calon F, Birdi S, Rajput AH, Hornykiewicz O, B\u00e9dard PJ, Di Paolo T (2002) Increase of preproenkephalin mRNA levels in the putamen of Parkinson disease patients with levodopa-induced dyskinesias. J Neuropathol Exp Neurol 61:186\u2013196","journal-title":"J Neuropathol Exp Neurol"},{"key":"1739_CR44","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.biopsych.2005.05.044","volume":"59","author":"N Pav\u00f3n","year":"2006","unstructured":"Pav\u00f3n N, Mart\u00edn AB, Mendialdua A, Moratalla R (2006) ERK phosphorylation and FosB expression are associated with L-DOPA-induced dyskinesia in hemiparkinsonian mice. Biol Psychiatry 59:64\u201374","journal-title":"Biol Psychiatry"},{"key":"1739_CR45","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.biopsych.2009.04.025","volume":"66","author":"S Darmopil","year":"2009","unstructured":"Darmopil S, Mart\u00edn AB, De Diego IR, Ares S, Moratalla R (2009) Genetic inactivation of dopamine D1 but not D2 receptors inhibits L-DOPA-induced dyskinesia and histone activation. Biol Psychiatry 66:603\u2013613","journal-title":"Biol Psychiatry"},{"key":"1739_CR46","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.biopsych.2014.03.023","volume":"77","author":"I Ruiz-DeDiego","year":"2015","unstructured":"Ruiz-DeDiego I, Mellstrom B, Vallejo M, Naranjo JR, Moratalla R (2015) Activation of DREAM (downstream regulatory element antagonistic modulator), a calcium-binding protein, reduces L-DOPA-induced dyskinesias in mice. Biol Psychiatry 77:95\u2013105","journal-title":"Biol Psychiatry"},{"key":"1739_CR47","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.expneurol.2016.03.024","volume":"280","author":"S Sgroi","year":"2016","unstructured":"Sgroi S, Capper-Loup C, Paganetti P, Kaelin-Lang A (2016) Enkephalin and dynorphin neuropeptides are differently correlated with locomotor hypersensitivity and levodopa-induced dyskinesia in parkinsonian rats. Exp Neurol 280:80\u201388","journal-title":"Exp Neurol"},{"key":"1739_CR48","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.nbd.2004.07.005","volume":"17","author":"C Konradi","year":"2004","unstructured":"Konradi C, Westin JE, Carta M, Eaton ME, Kuter K, Dekundy A, Lundblad M, Cenci MA (2004) Transcriptome analysis in a rat model of L-DOPA-induced dyskinesia. Neurobiol Dis 17:219\u2013236","journal-title":"Neurobiol Dis"},{"key":"1739_CR49","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0079-6123(10)83011-0","volume":"183","author":"MA Cenci","year":"2010","unstructured":"Cenci MA, Konradi C (2010) Maladaptive striatal plasticity in L-DOPA-induced dyskinesia. Prog Brain Res 183:209\u2013233","journal-title":"Prog Brain Res"},{"key":"1739_CR50","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.tips.2005.12.003","volume":"27","author":"CP Muller","year":"2006","unstructured":"Muller CP, Huston JP (2006) Determining the region-specific contributions of 5-HT receptors to the psychostimulant effects of cocaine. Trends Pharmacol Sci 27:105\u2013112","journal-title":"Trends Pharmacol Sci"},{"key":"1739_CR51","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.neuropharm.2013.06.030","volume":"76","author":"KA Cunningham","year":"2014","unstructured":"Cunningham KA, Anastasio NC (2014) Serotonin at the nexus of impulsivity and cue reactivity in cocaine addiction. Neuropharmacology 76:460\u2013478","journal-title":"Neuropharmacology"},{"key":"1739_CR52","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1006\/nbdi.1999.0259","volume":"6","author":"M Andersson","year":"1999","unstructured":"Andersson M, Hilbertson A, Cenci MA (1999) Striatal fosB expression is causally linked with l-DOPA-induced abnormal involuntary movements and the associated upregulation of striatal prodynorphin mRNA in a rat model of Parkinson\u2019s disease. Neurobiol Dis 6:461\u2013474","journal-title":"Neurobiol Dis"},{"key":"1739_CR53","unstructured":"Solis O, Garcia-Montes JR, Gonz\u00e1lez-Granillo A, Xu M, Moratalla R (2017) Dopamine D3 receptor modulates l-DOPA-induced dyskinesia by targeting D1 receptor-mediated striatal signaling. Cereb Cortex 27:435\u2013446"},{"key":"1739_CR54","doi-asserted-by":"crossref","first-page":"5042","DOI":"10.1523\/JNEUROSCI.22-12-05042.2002","volume":"22","author":"CR Gerfen","year":"2002","unstructured":"Gerfen CR, Miyachi S, Paletzki R, Brown P (2002) D1 dopamine receptor supersensitivity in the dopamine-depleted striatum results from a switch in the regulation of ERK1\/2\/MAP kinase. J Neurosci 22:5042\u20135054","journal-title":"J Neurosci"},{"key":"1739_CR55","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/B978-0-12-374767-9.00028-7","volume-title":"Handbook of basal ganglia structure and function","author":"CR Gerfen","year":"2010","unstructured":"Gerfen CR (2010) D1 dopamine receptor supersensitivity in the dopamine-depleted striatum: Aberrant ERK1\/2 signaling. In: Steiner H, Tseng KY (eds) Handbook of basal ganglia structure and function. Academic Press\/Elsevier, London, pp. 491\u2013500"},{"key":"1739_CR56","first-page":"639","volume-title":"Handbook of basal ganglia structure and function","author":"H Steiner","year":"2017","unstructured":"Steiner H (2017) Psychostimulant-induced gene regulation in striatal circuits. In: Steiner H, Tseng KY (eds) Handbook of basal ganglia structure and function, 2nd edn. Academic Press\/Elsevier, London, pp. 639\u2013672","edition":"2"},{"key":"1739_CR57","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/j.1460-9568.1993.tb00959.x","volume":"5","author":"MA Cenci","year":"1993","unstructured":"Cenci MA, Bj\u00f6rklund A (1993) Transection of corticostriatal afferents reduces amphetamine- and apomorphine-induced striatal Fos expression and turning behaviour in unilaterally 6-hydroxydopamine-lesioned rats. Eur J Neurosci 5:1062\u20131070","journal-title":"Eur J Neurosci"},{"key":"1739_CR58","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/syn.890180410","volume":"18","author":"JQ Wang","year":"1994","unstructured":"Wang JQ, Daunais JB, McGinty JF (1994) NMDA receptors mediate amphetamine-induced upregulation of zif\/268 and preprodynorphin mRNA expression in rat striatum. Synapse 18:343\u2013353","journal-title":"Synapse"},{"key":"1739_CR59","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/syn.890200404","volume":"20","author":"JM Vargo","year":"1995","unstructured":"Vargo JM, Marshall JF (1995) Time-dependent changes in dopamine agonist-induced striatal Fos immunoreactivity are related to sensory neglect and its recovery after unilateral prefrontal cortex injury. Synapse 20:305\u2013315","journal-title":"Synapse"},{"key":"1739_CR60","doi-asserted-by":"crossref","first-page":"5449","DOI":"10.1523\/JNEUROSCI.20-14-05449.2000","volume":"20","author":"H Steiner","year":"2000","unstructured":"Steiner H, Kitai ST (2000) Regulation of rat cortex function by D1 dopamine receptors in the striatum. J Neurosci 20:5449\u20135460","journal-title":"J Neurosci"},{"key":"1739_CR61","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.expneurol.2017.04.011","volume":"294","author":"M Alam","year":"2017","unstructured":"Alam M, Rumpel R, Jin X, von Wrangel C, Tschirner SK, Krauss JK, Grothe C, Ratzka A et al (2017) Altered somatosensory cortex neuronal activity in a rat model of Parkinson\u2019s disease and levodopa-induced dyskinesias. Exp Neurol 294:19\u201331","journal-title":"Exp Neurol"},{"key":"1739_CR62","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3389\/fnana.2011.00051","volume":"5","author":"MG Murer","year":"2011","unstructured":"Murer MG, Moratalla R (2011) Striatal signaling in L-DOPA-induced dyskinesia: common mechanisms with drug abuse and long term memory involving D1 dopamine receptor stimulation. Front Neuroanat 5:51","journal-title":"Front Neuroanat"},{"key":"1739_CR63","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1172\/JCI90132","volume":"127","author":"C Alcacer","year":"2017","unstructured":"Alcacer C, Andreoli L, Sebastianutto I, Jakobsson J, Fieblinger T, Cenci MA (2017) Chemogenetic stimulation of striatal projection neurons modulates responses to Parkinson\u2019s disease therapy. J Clin Invest 127:720\u2013734","journal-title":"J Clin Invest"},{"key":"1739_CR64","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/mds.26947","volume":"32","author":"L F Hern\u00e1ndez","year":"2017","unstructured":"F Hern\u00e1ndez L, Castela I, Ruiz-DeDiego I, Obeso JA, Moratalla R (2017) Striatal activation by optogenetics induces dyskinesias in the 6-hydroxydopamine rat model of Parkinson disease. Mov Disord 32:530\u2013537","journal-title":"Mov Disord"},{"key":"1739_CR65","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.neuron.2018.01.017","volume":"97","author":"AE Girasole","year":"2018","unstructured":"Girasole AE, Lum MY, Nathaniel D, Bair-Marshall CJ, Guenthner CJ, Luo L, Kreitzer AC, Nelson AB (2018) A subpopulation of striatal neurons mediates levodopa-induced dyskinesia. Neuron 97:787\u2013795","journal-title":"Neuron"},{"key":"1739_CR66","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.1016\/j.celrep.2018.05.059","volume":"23","author":"MB Ryan","year":"2018","unstructured":"Ryan MB, Bair-Marshall C, Nelson AB (2018) Aberrant striatal activity in parkinsonism and levodopa-induced dyskinesia. Cell Rep 23:3438\u20133446","journal-title":"Cell Rep"},{"key":"1739_CR67","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1111\/bph.14663","volume":"176","author":"E Keifman","year":"2019","unstructured":"Keifman E, Ruiz-DeDiego I, Pafundo DE, Paz RM, Sol\u00eds O, Murer MG, Moratalla R (2019) Optostimulation of striatonigral terminals in substantia nigra induces dyskinesia that increases after L-DOPA in a mouse model of Parkinson\u2019s disease. Br J Pharmacol 176:2146\u20132161","journal-title":"Br J Pharmacol"},{"key":"1739_CR68","first-page":"423","volume-title":"Handbook of basal ganglia structure and function","author":"HJ Groenewegen","year":"2017","unstructured":"Groenewegen HJ, Wouterlood FG, Uylings HBM (2017) Organization of prefrontal-striatal connections. In: Steiner H, Tseng KY (eds) Handbook of basal ganglia structure and function, 2nd edn. Academic Press\/Elsevier, London, pp. 423\u2013438","edition":"2"},{"key":"1739_CR69","first-page":"535","volume-title":"Handbook of basal ganglia structure and function","author":"SN Haber","year":"2017","unstructured":"Haber SN (2017) Integrative networks across basal ganglia circuits. In: Steiner H, Tseng KY (eds) Handbook of basal ganglia structure and function, 2nd edn. Academic Press\/Elsevier, London, pp. 535\u2013552","edition":"2"},{"key":"1739_CR70","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1146\/annurev.ne.09.030186.002041","volume":"9","author":"GE Alexander","year":"1986","unstructured":"Alexander GE, DeLong MR, Strick PL (1986) Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 9:357\u2013381","journal-title":"Annu Rev Neurosci"},{"key":"1739_CR71","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0306-4522(94)90536-3","volume":"63","author":"D Joel","year":"1994","unstructured":"Joel D, Weiner I (1994) The organization of the basal ganglia-thalamocortical circuits: open interconnected rather than closed segregated. Neuroscience 63:363\u2013379","journal-title":"Neuroscience"},{"key":"1739_CR72","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1523\/JNEUROSCI.20-06-02369.2000","volume":"20","author":"SN Haber","year":"2000","unstructured":"Haber SN, Fudge JL, McFarland NR (2000) Striatonigrostriatal pathways in primates form an ascending spiral from the shell to the dorsolateral striatum. J Neurosci 20:2369\u20132382","journal-title":"J Neurosci"},{"key":"1739_CR73","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1093\/brain\/awm082","volume":"130","author":"M Carta","year":"2007","unstructured":"Carta M, Carlsson T, Kirik D, Bj\u00f6rklund A (2007) Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats. Brain 130:1819\u20131833","journal-title":"Brain"},{"key":"1739_CR74","doi-asserted-by":"crossref","first-page":"242","DOI":"10.3389\/fneur.2014.00242","volume":"5","author":"MA Cenci","year":"2014","unstructured":"Cenci MA (2014) Presynaptic mechanisms of l-DOPA-induced dyskinesia: the findings, the debate, and the therapeutic implications. Front Neurol 5:242","journal-title":"Front Neurol"},{"key":"1739_CR75","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1002\/mds.25366","volume":"28","author":"E Bezard","year":"2013","unstructured":"Bezard E, Tronci E, Pioli EY, Li Q, Porras G, Bj\u00f6rklund A, Carta M (2013) Study of the antidyskinetic effect of eltoprazine in animal models of levodopa-induced dyskinesia. Mov Disord 28:1088\u20131096","journal-title":"Mov Disord"},{"key":"1739_CR76","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1093\/brain\/awu409","volume":"138","author":"P Svenningsson","year":"2015","unstructured":"Svenningsson P, Rosenblad C, Af Edholm Arvidsson K, Wictorin K, Keywood C, Shankar B, Lowe DA, Bj\u00f6rklund A et al (2015) Eltoprazine counteracts l-DOPA-induced dyskinesias in Parkinson\u2019s disease: a dose-finding study. Brain 138:963\u2013973","journal-title":"Brain"},{"key":"1739_CR77","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.expneurol.2017.03.013","volume":"292","author":"SM Meadows","year":"2017","unstructured":"Meadows SM, Chambers NE, Conti MM, Bossert SC, Tasber C, Sheena E, Varney M, Newman-Tancredi A et al (2017) Characterizing the differential roles of striatal 5-HT1A auto- and hetero-receptors in the reduction of l-DOPA-induced dyskinesia. Exp Neurol 292:168\u2013178","journal-title":"Exp Neurol"},{"key":"1739_CR78","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0306-4522(94)90164-3","volume":"58","author":"U Boschert","year":"1994","unstructured":"Boschert U, Amara DA, Segu L, Hen R (1994) The mouse 5-hydroxytryptamine1B receptor is localized predominantly on axon terminals. Neuroscience 58:167\u2013182","journal-title":"Neuroscience"},{"key":"1739_CR79","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0306-4522(98)00256-5","volume":"88","author":"Y Sari","year":"1999","unstructured":"Sari Y, Miquel MC, Brisorgueil MJ, Ruiz G, Doucet E, Hamon M, Verg\u00e9 D (1999) Cellular and subcellular localization of 5-hydroxytryptamine1B receptors in the rat central nervous system: immunocytochemical, autoradiographic and lesion studies. Neuroscience 88:899\u2013915","journal-title":"Neuroscience"},{"key":"1739_CR80","doi-asserted-by":"crossref","first-page":"7566","DOI":"10.1523\/JNEUROSCI.16-23-07566.1996","volume":"16","author":"IM Stanford","year":"1996","unstructured":"Stanford IM, Lacey MG (1996) Differential actions of serotonin, mediated by 5-HT1B and 5-HT2C receptors, on GABA-mediated synaptic input to rat substantia nigra pars reticulata neurons in vitro. J Neurosci 16:7566\u20137573","journal-title":"J Neurosci"},{"key":"1739_CR81","doi-asserted-by":"crossref","first-page":"3397","DOI":"10.1152\/jn.00831.2014","volume":"113","author":"S Ding","year":"2015","unstructured":"Ding S, Li L, Zhou FM (2015) Robust presynaptic serotonin 5-HT(1B) receptor inhibition of the striatonigral output and its sensitization by chronic fluoxetine treatment. J Neurophysiol 113:3397\u20133409","journal-title":"J Neurophysiol"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-019-01739-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-019-01739-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-019-01739-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T17:04:03Z","timestamp":1695143043000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-019-01739-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,29]]},"references-count":81,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["1739"],"URL":"https:\/\/doi.org\/10.1007\/s12035-019-01739-x","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,29]]},"assertion":[{"value":"10 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}